Jun 30, 2023

Arcturus Therapeutics Q2 2023 Earnings Report

Total Revenue
$10.5M
Previous year: $27.1M
-61.2%
EPS
-$1.98
Previous year: -$0.82
+141.5%
Gross Profit
$10.5M
Previous year: $27.1M
-61.2%
Cash and Equivalents
$323M
Previous year: $283M
+14.1%
Free Cash Flow
$50.5M
Previous year: -$36.4M
-238.4%
Total Assets
$431M
Previous year: $337M
+27.8%

Arcturus Therapeutics

Arcturus Therapeutics